typical vendors What you actually get when you order from Kalon, compared with a typical mid-tier research peptide vendor
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
However, complete tears generally require surgery, peptides not substitute for necessary operations
Our Certificate of Analysis is available for download below
Janoshik Verified COA Independent third-party testing for compound identity, purity and quality
Does vitamin B12 injection dosage vary based on deficiency levels